(Q45172544)

10 December 2017

title

A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy (English)

1 reference

10 December 2017

1 reference

Kentaro Toyota

1

1 reference

10 December 2017

Taeko Hashimoto

2

1 reference

10 December 2017

Daisuke Ogino

3

1 reference

10 December 2017

Akira Matsunaga

4

1 reference

10 December 2017

Minoru Ito

5

1 reference

10 December 2017

Ikuto Masakane

6

1 reference

10 December 2017

Noriyuki Degawa

7

1 reference

10 December 2017

Hiroshi Sato

8

1 reference

10 December 2017

Sayuri Shirai

9

1 reference

10 December 2017

Kazuo Umetsu

10

1 reference

10 December 2017

Gen Tamiya

11

1 reference

10 December 2017

Takao Saito

12

1 reference

10 December 2017

Kiyoshi Hayasaka

13

1 reference

10 December 2017

publication date

14 February 2013

1 reference

Journal of Human Genetics

10 December 2017

published in

1 reference

10 December 2017

volume

58

1 reference

10 December 2017

issue

5

1 reference

10 December 2017

page(s)

254-258

1 reference

https://scigraph.springernature.com/pub.10.1038/jhg.2013.8

10 December 2017

exact match

0 references

cites work

Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

Lipoprotein glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

7 January 2021

A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

7 January 2021

APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

7 January 2021

A rare cause of posttransplantation nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

7 January 2021

Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

7 January 2021

Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.8

7 January 2021

Identifiers

DOI

10.1038/JHG.2013.8

1 reference

Dimensions Publication ID

10 December 2017

1050531182

0 references

1 reference